IGRYPH
Pharmaceutical preparations for use in infectious diseases, viral diseases, cancer, autoimmune diseases, central nervous system disorders, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, oncological conditions, ophthalmologic diseases, respiratory diseases, thrombotic diseases, vascular diseases, and inflammation
Abandoned · October 9, 2007 · 77299739 ·
